Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Purushottam M Dewang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsPurushottam M Dewang, Dae-Kee Kim
Journal of Combinatorial Chemistry|November 9, 2004
Traceless solid-phase synthesis of carbolinonesMeei-Shiou Chern, Ying-Kai Shih, Purushottam M Dewang, et al.
European Journal of Medicinal Chemistry|May 10, 2008
Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsDae-Kee Kim, Sun Hee Jung, Ho Soon Lee, et al.
Current Medicinal Chemistry|January 11, 2005
Protein tyrosine phosphatases and their inhibitorsPurushottam M Dewang, Nai-Mu Hsu, Shao-Zheng Peng, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinaseDae-Kee Kim, Jin-Hwi Lim, Jung A Lee, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 14, 2020
Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1<i>H</i>-imidazoles as ALK5 inhibitorsMyoung-Soon Park, Hyun-Ju Park, Young Jae An, et al.
Bioorganic & Medicinal Chemistry|May 18, 2010
Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsDae-Kee Kim, Yeon-Im Lee, Yeon Woo Lee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsPurushottam M Dewang, Dae-Kee Kim
Journal of Combinatorial Chemistry|November 9, 2004
Traceless solid-phase synthesis of carbolinonesMeei-Shiou Chern, Ying-Kai Shih, Purushottam M Dewang, et al.
European Journal of Medicinal Chemistry|May 10, 2008
Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsDae-Kee Kim, Sun Hee Jung, Ho Soon Lee, et al.
Current Medicinal Chemistry|January 11, 2005
Protein tyrosine phosphatases and their inhibitorsPurushottam M Dewang, Nai-Mu Hsu, Shao-Zheng Peng, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinaseDae-Kee Kim, Jin-Hwi Lim, Jung A Lee, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 14, 2020
Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1<i>H</i>-imidazoles as ALK5 inhibitorsMyoung-Soon Park, Hyun-Ju Park, Young Jae An, et al.
Bioorganic & Medicinal Chemistry|May 18, 2010
Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitorsDae-Kee Kim, Yeon-Im Lee, Yeon Woo Lee, et al.
Pageof 1